Testosterone Replacement Therapy in Europe: What Men Should Know in 2026
A physician-reviewed guide to TRT in the EU — symptoms of low testosterone, how diagnosis works, treatment options, and how telehealth is changing access to men's hormone care.
For decades, testosterone replacement therapy was surrounded by taboo, misinformation, and limited access. In 2026, that's changing — especially in Europe, where telehealth has opened up physician-led TRT to men who previously had no realistic path to diagnosis. Here's what every man should understand before considering treatment.
What Is Low Testosterone?
Testosterone is the primary male sex hormone, but it does far more than drive libido. It regulates:
- Muscle mass and strength
- Bone density
- Red blood cell production
- Mood and cognitive function
- Energy and sleep quality
- Fat distribution
- Cardiovascular health
Testosterone levels typically peak in the early twenties and decline by roughly 1% per year after age 30. For most men, this gradual decline is manageable. For others, it produces genuine clinical symptoms that affect quality of life.
Symptoms of Low Testosterone
Common signs that warrant testing:
- Persistent fatigue despite adequate sleep
- Reduced libido or erectile issues
- Loss of muscle mass or difficulty building it
- Increased abdominal fat
- Low mood, irritability, or brain fog
- Reduced motivation and drive
- Poor recovery from exercise
- Disrupted sleep
These symptoms overlap with many other conditions, which is why self-diagnosis is unreliable. Proper testing is essential.
How Diagnosis Actually Works
A legitimate TRT evaluation includes:
- Symptom assessment — structured clinical questionnaires
- Morning blood test — total testosterone, free testosterone, SHBG, LH, FSH, oestradiol
- Confirmation test — a second morning test to rule out transient dips
- Comprehensive panel — thyroid, prolactin, PSA, lipids, liver, full blood count
- Physician interpretation — contextualising results with symptoms and medical history
Note the word morning. Testosterone peaks between 7–10 AM, so afternoon tests often produce misleadingly low results.
EU Clinical Thresholds
European endocrine guidelines generally consider treatment when:
- Total testosterone is consistently below 12 nmol/L (around 350 ng/dL), AND
- Clinical symptoms of hypogonadism are present
Treatment is not recommended based on lab values alone, or based on symptoms alone. Both are required.
Treatment Options
Modern TRT uses several delivery methods, each with trade-offs:
Injections — most common, administered weekly or bi-weekly. Stable levels, lower cost, requires self-injection.
Topical gels — daily application. Convenient but risks transferring to family members through skin contact.
Pellets — implanted subcutaneously every 3–6 months. Long-acting but requires a minor procedure.
Oral formulations — newer options that bypass the liver. Emerging choice in EU markets.
Choice depends on lifestyle, cost, tolerance, and physician recommendation.
What About Side Effects?
Properly managed TRT is generally well-tolerated, but physicians monitor for:
- Elevated red blood cell count (haematocrit)
- Changes in PSA
- Acne or skin changes
- Fluid retention
- Fertility impact (TRT typically reduces sperm production)
Ongoing bloodwork every 3–6 months is essential. TRT without monitoring is TRT done wrong.
How EU Telehealth Is Changing TRT Access
Historically, getting a TRT consultation in Europe meant GP referrals, endocrinology waiting lists, and often being told your levels were "within range" even when you had clear symptoms. Telehealth has changed this by:
- Providing direct access to physicians experienced in men's hormone health
- Integrating bloodwork through partner labs across the EU
- Enabling ongoing monitoring through secure messaging
- Delivering prescriptions through licensed EU pharmacies
The best platforms combine clinical rigour with convenience — not one at the expense of the other.
A Word on Underground TRT
Some men bypass the medical system entirely using unregulated sources. This is dangerous for several reasons:
- No way to verify product purity
- No medical oversight of dosing or side effects
- No monitoring of haematocrit, PSA, or other markers
- Legal risk in most EU countries
- Risk of injecting contaminated compounds
If you're considering TRT, there's now a legitimate, affordable path through EU telehealth. The underground route offers no advantage — and significant risk.
TRT is a long-term medical commitment that should only be undertaken with proper diagnosis and ongoing physician supervision. If you're experiencing symptoms, start with a physician consultation and proper bloodwork.
Ready to take control of your health?
Get matched with an EU-licensed physician in minutes.
Start Free Assessment